Join to access to all OVN content. Join for Free
How to Build Scientific Credibility for Continuous Career Development
Scientific Credibility Medical Affairs Career Development KOL Relationships Professional Challenges

How to Build Scientific Credibility for Continuous Career Development


Share This Article


Summary

My guest this week is Ike Ogbaa, Vice President and Head of Medical Affairs who discusses How to Build Scientific Credibility for Continuous Career Development.

My guest this week is Ike Ogbaa, Vice President and Head of Medical Affairs who discusses How to Build Scientific Credibility for Continuous Career Development

Learn more about…

๐Ÿ‘‰ Why is scientific credibility so important for medical affairs professionals
๐Ÿ‘‰ How can people assess gaps and identify areas of improvement
๐Ÿ‘‰ How does scientific credibility influence ability to create KOL relationships and build trust
๐Ÿ‘‰ How can medical affairs professionals utilize internal stakeholders
๐Ÿ‘‰ What are some challenges professional face when trying to develop scientific credibility

Click for Source
Scientific Credibility, Medical Affairs, Career Development, KOL Relationships, Professional Challenges

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Empowering people to drive medical affairs performance with AI
Partner Avatar Envision Pharma Group

Empowering people to drive medical affairs performance with AI

Article
Medical affairs: The power behind redefining commercialization
Partner Avatar Envision Pharma Group

Medical affairs: The power behind redefining commercialization

Podcast
The Struggle With KOL Access in Todays World
Partner Avatar MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper

The Struggle With KOL Access in Todays World

Podcast
Interim Impact The Rise of Fractional Medical Affairs Roles in Pharmas New Reality
Partner Avatar MSL Talk: Tom Caravela, Daniel Snyder

Interim Impact The Rise of Fractional Medical Affairs Roles in Pharmas New Reality

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Explore OVN